Warning! GuruFocus detected
1 Severe warning sign
with SLRN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Acelyrin Inc
NAICS : 541714
SIC : 2834
ISIN : US00445A1007
Description
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 71.43 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -14.5 | |||||
| 3-Year EPS without NRI Growth Rate | -5.2 | |||||
| 3-Year FCF Growth Rate | -28 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.26 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.96 | |||||
| 9-Day RSI | 37.32 | |||||
| 14-Day RSI | 45.33 | |||||
| 3-1 Month Momentum % | -18.93 | |||||
| 6-1 Month Momentum % | -46.23 | |||||
| 12-1 Month Momentum % | -61.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 18.1 | |||||
| Quick Ratio | 18.1 | |||||
| Cash Ratio | 16.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -70 | |||||
| Shareholder Yield % | -0.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -43.47 | |||||
| ROA % | -38.77 | |||||
| ROIC % | -1888.83 | |||||
| 3-Year ROIIC % | -1076.74 | |||||
| ROC (Joel Greenblatt) % | -5778.76 | |||||
| ROCE % | -53.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.55 | |||||
| EV-to-EBIT | 0.62 | |||||
| EV-to-Forward-EBIT | -0.02 | |||||
| EV-to-EBITDA | 0.62 | |||||
| EV-to-FCF | 0.58 | |||||
| Price-to-Net-Current-Asset-Value | 0.56 | |||||
| Price-to-Net-Cash | 0.61 | |||||
| Earnings Yield (Greenblatt) % | 161.29 | |||||
| FCF Yield % | -120.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Acelyrin Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.5 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 90.38 | ||
| 14-Day RSI | 45.33 | ||
| 14-Day ATR ($) | 0.144025 | ||
| 20-Day SMA ($) | 2.67025 | ||
| 12-1 Month Momentum % | -61.87 | ||
| 52-Week Range ($) | 1.845 - 7.25 | ||
| Shares Outstanding (Mil) | 100.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acelyrin Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acelyrin Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acelyrin Inc Frequently Asked Questions
What is Acelyrin Inc(SLRN)'s stock price today?
The current price of SLRN is $2.52. The 52 week high of SLRN is $7.25 and 52 week low is $1.85.
When is next earnings date of Acelyrin Inc(SLRN)?
The next earnings date of Acelyrin Inc(SLRN) is 2025-03-28 Est..
Does Acelyrin Inc(SLRN) pay dividends? If so, how much?
Acelyrin Inc(SLRN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers